StudyRareStudyRare

NARP (neuropathy, ataxia, retinitis pigmentosa)

Log in to star

Last updated Nov 4, 2026

Log in to add personal notes on this page.

A young adult with developmental delay has progressive ataxia, peripheral neuropathy, and night blindness. Retinitis pigmentosa is found on fundoscopy.

Maternal (mtDNA); MT-ATP6 m.8993T>G or T>C (ATP synthase subunit a, complex V). Heteroplasmic loss of function: the mutant load sets the phenotype.

  • Same gene as some Leigh syndrome cases
  • Higher mutant load (>90%) → Leigh syndrome
  • Lower mutant load (70-90%) → NARP

MT-ATP6 encodes subunit a of ATP synthase (complex V), one of the 13 respiratory chain and oxidative phosphorylation subunits made inside mitochondria. Pathogenic variants in such protein-coding genes lower the activity of the complex they belong to, so ATP output falls and tissues with high energy demand fail first. (The N in NARP is neurogenic muscle weakness.)

The m.8993 variants have the strongest genotype-phenotype correlation of any mtDNA variant, because their level varies little between tissues or with age:

  • m.8993T>G: below 60%, usually no symptoms or only mild pigmentary retinopathy or migraine; 70% to 90%, NARP; above 90%, typically Leigh syndrome. Bands overlap, and some adults with up to 75% are well.
  • m.8993T>C: milder; symptomatic people generally carry more than 90%, and some with that level are well.

The higher severity of T>G is unexplained; instability of the abnormal protein is suspected. A mother's level predicts recurrence risk, though with wide confidence intervals, and the level stays fairly stable through fetal development, which supports prenatal testing. Muscle biopsy is usually normal or nonspecific, with only occasional ragged red fibers.

respiratory chain, inner membranesubunits from nuclear andmitochondrial DNA; complex I andcomplex IV deficiencies are themost common Leigh defectsLeigh syndromeATP synthase (complex V)MT-ATP6; subunit aNARPLeigh syndrome (higher mutantloads)NADH, FADH2complexes I to IVATP
Excerpt from pyruvate oxidation and the respiratory chain. See the full pathway.

Part of pyruvate oxidation and the respiratory chain.

Oxidative phosphorylation, the final ATP-making step.

Krebs cycle → NADH, FADH2 → respiratory chain complexes I to IV → ATP synthase, complex V (the block; MT-ATP6 subunit a) → ATP

  • Accumulates: lactate during decompensation at the Leigh end of the spectrum; the measurement that predicts severity is the m.8993 heteroplasmy level.
  • Missing: ATP in tissues with high energy demand.
  • Workbook: 9.B. Heteroplasmy
  • Peripheral neuropathy (sensory)
  • Cerebellar ataxia
  • Retinitis pigmentosa
  • Developmental delay/cognitive impairment
  • Proximal muscle weakness
  • Seizures (some)
  • Overlaps with Leigh syndrome at high heteroplasmy
  • Targeted mtDNA testing for MT-ATP6 m.8993T>G or T>C, with heteroplasmy quantification (severity tracks mutant load)
  • Fundoscopy confirms retinitis pigmentosa; brain MRI may show cerebellar/brainstem changes
  • Unlike many mitochondrial disorders, muscle biopsy typically does not show ragged red fibers
  • Largely supportive (no disease-modifying therapy): low-vision support, physical therapy for ataxia, anticonvulsants for seizures
  • Maternally inherited (mtDNA): all offspring of an affected mother are at risk, and heteroplasmy makes recurrence severity unpredictable

NARP = the diagnosis: the name itself is the mnemonic: Neuropathy, Ataxia, Retinitis Pigmentosa. All three cardinal features are in the name.

Same gene, different load: MT-ATP6 mutations at m.8993 show lower heteroplasmy (70-90%) causing NARP, while higher mutant load (>90%) causes the more severe Leigh syndrome.

Reference Links